Varenicline and accelerated TMS to help adults stop nicotine use
About this title
Read the official source — NCT07145866Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
Participants take the medication varenicline for twelve weeks, complete questionnaires and have MRI (magnetic resonance imaging) scans. The protocol compares active accelerated transcranial magnetic stimulation with D-cycloserine against simulated stimulation with a placebo (an inactive comparison treatment); both groups take varenicline.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Behavioural, Device, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07145866
- Official title
Show the full official title
Evaluation of Varenicline and Accelerated TMS for Reduction of Nicotine Use
Recruitment & locations
Boston
Interested in joining this study?
Questions about this study
What will I need to do?
You will take study medication.
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Varenicline and D-cycloserine.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
